|
KPNB1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.067600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.361400E-03 |
| Normal-vs-Stage2 |
7.037800E-01 |
| Normal-vs-Stage3 |
3.872600E-01 |
| Normal-vs-Stage4 |
1.091230E-01 |
| Stage1-vs-Stage2 |
1.379020E-01 |
| Stage1-vs-Stage3 |
2.006600E-01 |
| Stage1-vs-Stage4 |
8.696200E-01 |
| Stage2-vs-Stage3 |
7.532000E-01 |
| Stage2-vs-Stage4 |
3.264800E-01 |
| Stage3-vs-Stage4 |
4.324400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.700480E-02 |
| Normal-vs-AfricanAmerican |
9.818000E-01 |
| Normal-vs-Asian |
2.299000E-01 |
| Caucasian-vs-AfricanAmerican |
1.478630E-01 |
| Caucasian-vs-Asian |
2.135200E-01 |
| AfricanAmerican-vs-Asian |
1.182560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.351250E-01 |
| Normal-vs-Female |
2.880200E-03 |
| Male-vs-Female |
6.463900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.416200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.255760E-02 |
| Normal-vs-Age(61-80Yrs) |
4.409800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.299600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.172200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.587000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.036600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.745000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.650300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.840100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.392300E-04 |
| Normal-vs-Grade 2 |
6.062800E-03 |
| Normal-vs-Grade 3 |
2.554600E-01 |
| Normal-vs-Grade 4 |
1.873250E-01 |
| Grade 1-vs-Grade 2 |
1.481780E-01 |
| Grade 1-vs-Grade 3 |
7.468500E-02 |
| Grade 1-vs-Grade 4 |
2.189400E-01 |
| Grade 2-vs-Grade 3 |
1.279990E-01 |
| Grade 2-vs-Grade 4 |
7.329800E-01 |
| Grade 3-vs-Grade 4 |
5.321000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.72150000000394E-05 |
| Normal-vs-ccB subtype |
2.112800E-01 |
| ccA subtype-vs-ccB subtype |
4.467800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.593500E-02 |
| Normal-vs-N1 |
1.058360E-01 |
| N0-vs-N1 |
2.476200E-01 |
|
|
